A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions
Open Access
- 1 October 2005
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 58 (10), 1096-1100
- https://doi.org/10.1136/jcp.2004.025072
Abstract
Background: A shifted balance between T helper 1 (Th1)-type and Th2-type cytokines has been hypothesised in cervical dysplasia Aims: To evaluate possible deregulation of the cytokine network by estimating the expression of peripheral cytokines in different stages of cervical disease and in relation to the presence or absence of high risk human papillomavirus (HR-HPV). Methods: Twenty one HR-HPV positive women with high grade cervical intraepithelial neoplasia (CIN II–III) and 12 patients with invasive cervical carcinoma formed the study groups. Two control groups consisted of 10 HR-HPV positive and 11 HR-HPV negative women without CIN. Differences in leucocyte subgroups were evaluated by a differential leucocyte count. Plasma concentrations of tumour necrosis factor α (TNFα), TNFα receptors TNFRI and TNFRII, interferon γ (IFNγ), interleukin 2 (IL-2), IL-12, IL-4, and IL-10 were determined by enzyme linked immunosorbent assays. Results: Leucocyte counts in patients with CIN III and carcinoma were significantly higher than in controls. Plasma IFNγ concentrations were significantly lower in patients with CIN III and carcinoma than in women with CIN II or controls. Plasma concentrations of IL-12, IL-2, IL-4, and TNFα did not differ significantly between groups, but significantly lower plasma concentrations of TNFRII were found in CIN III and carcinoma compared with CIN II. IL-10 was detected with increased frequency in the plasma of patients with CIN III and carcinoma. Conclusions: These results indicate that a shift to a Th2-type cytokine pattern during the carcinogenesis of cervical cancer occurs in women with CIN III lesions.Keywords
This publication has 33 references indexed in Scilit:
- Persistence of Human Papillomavirus Infection in HIV‐Infected and ‐Uninfected Adolescent Girls: Risk Factors and Differences, by Phylogenetic TypeThe Journal of Infectious Diseases, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STDInternational Journal of Gynecologic Cancer, 2002
- Serum Cytokine Concentrations in Patients with Cervical Cancer: Interleukin-4, Interferon-γ, and Monocyte Chemoattractant Protein-1Gynecologic Oncology, 2001
- Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesionsInternational Journal of Cancer, 1997
- Analysis of Cytokine Profiles in Patients With Human Papillomavirus-Associated NeoplasmsJNCI Journal of the National Cancer Institute, 1997
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993
- Lymphoid cell distribution as prognostic factor in carcinoma of the uterine cervixActa Obstetricia et Gynecologica Scandinavica, 1992
- Evaluation of circulating tumor necrosis factor‐α in patients with gynecological malignanciesInternational Journal of Cancer, 1991